Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Structure00:56

Viral Structure

73.0K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
73.0K
Introduction to Virus01:28

Introduction to Virus

886
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
886
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

76.8K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
76.8K
DNA Bacteriophages01:26

DNA Bacteriophages

556
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
556
Subviral Agents01:29

Subviral Agents

355
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
355
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

522
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
522

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Light and Dark Cycles Control the Structural Evolution of Photoresponsive Supramolecular Systems.

Angewandte Chemie (International ed. in English)·2026
Same author

3D self-assembly of cyclic peptides into multilayered nanosheets.

Chemical science·2026
Same author

Clickable Polymer-Based Coatings for Modulating the Interaction of Metal-Organic Framework Nanocrystals with Living Cells.

ACS applied materials & interfaces·2025
Same author

mRNA delivery with templated dynamic covalent polymers.

Chemical communications (Cambridge, England)·2025
Same author

A non-hydrolysable peptidomimetic for mitochondrial targeting.

Journal of materials chemistry. B·2025
Same author

Supramolecular fibrillation in coacervates and other confined systems towards biomimetic function.

Communications chemistry·2024

Related Experiment Video

Updated: Dec 10, 2025

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.2K

Stronger Together: Multivalent Phage Capsids Inhibit Virus Entry.

Iván Gallego1, Irene Lostalé-Seijo1, Javier Montenegro1

  • 1Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS) Departamento de Química Orgánica, Universidade de Santiago de Compostela, Campus Vida, 15782, Santiago de Compostela, Spain.

Chembiochem : a European Journal of Chemical Biology
|August 29, 2020
PubMed
Summary

Developing new antiviral strategies is crucial. This study uses a phage capsid scaffold to position sialic acid, effectively inhibiting influenza A virus replication by disrupting viral receptor binding.

Keywords:
antiviralscooperative effectsglycoconjugatesprotein engineeringviruses

More Related Videos

In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation
07:24

In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation

Published on: March 27, 2016

9.4K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.7K

Related Experiment Videos

Last Updated: Dec 10, 2025

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16
06:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

8.2K
In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation
07:24

In Vitro Disassembly of Influenza A Virus Capsids by Gradient Centrifugation

Published on: March 27, 2016

9.4K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.7K

Area of Science:

  • Virology
  • Biotechnology
  • Drug Discovery

Background:

  • Antiviral therapies are essential for managing viral infections.
  • Effective inhibition requires high-affinity interactions to block virus-receptor binding.
  • Influenza A virus poses a significant public health threat.

Purpose of the Study:

  • To present a novel phage capsid scaffold strategy for antiviral applications.
  • To investigate the precise positioning of sialic acid moieties for enhanced antiviral activity.
  • To demonstrate the inhibition of influenza A virus replication using this approach.

Main Methods:

  • Utilizing a phage capsid as a scaffold for precise molecular positioning.
  • Synthesizing and attaching sialic acid moieties to the phage capsid.
  • Assessing the binding affinity and inhibitory effects against influenza A virus.

Main Results:

  • The phage capsid scaffold successfully positioned sialic acid moieties with high precision.
  • The engineered scaffold demonstrated significant inhibition of influenza A virus replication.
  • The strategy effectively overcame the natural binding affinity between the virus and its receptor.

Conclusions:

  • Phage capsid scaffolds offer a promising platform for developing multivalent antiviral strategies.
  • Precise positioning of viral receptor ligands can lead to potent antiviral agents.
  • This method provides a new avenue for combating influenza A virus and potentially other viral pathogens.